Абстрактный

Evolution of the human brain development: Starring the subplate.

Ronald Hoy

There currently is not yet a consensus in the field on which imaging measures have the greatest utility as biomarkers for clinical trials in AP. Recent systematic reviews on available neuroimaging biomarkers for diagnosis and progression of AP disclosed that despite a plethora of studies, these have not yet yielded sufficiently validated biomarkers for diagnosis and disease progression, especially in the early course of disease or newly recognized variants. This is problematic not only for finding a consensus but also because standard performance measures for newly developed imaging biomarkers are missing.